biotricity is changing the healthcare industry

by developing medical remote monitoring solutions that help prevent and manage chronic diseases.

What we do


biotricity is focused on delivering leading-edge, medically relevant biometric monitoring solutions for medical, healthcare and consumer use.


Evolving healthcare one step at a time.

Our goal is to evolve the healthcare industry to help physicians better monitor their patients. At the same time, we empower individuals to manage their risk of cardiac issues and heart disease to live a better life, stay active and enjoy every day to the fullest.

To bring this vision to life, we’ve created two ECG monitoring devices designed to improve upon the tools and devices currently available in today’s marketplace.

biotricity aims to go above and beyond the Mobile Cardiac Telemetry (MCT) market by providing a turnkey, wearable medical cardiac monitoring solution. Our devices are developed with ongoing input from doctors, so every aspect of the medical profession is consulted in everything we do.

To achieve this, we are dedicated to:

  • R&D
  • honing our medical-device expertise
  • increasing our deep knowledge of biometrics
  • developing both software and hardware components
  • nurturing a cohesive medical network

For Physicians

bioflux is a medical technology solution for physicians to test and diagnose patients, and benefit from an innovative system that offers continuous active monitoring for up to 30 consecutive days.
Learn more

For Consumers

biolife is a preventative care solution for consumers. biolife leverages the expertise gained from bioflux and is designed to help individuals track their progress in real-time so they can stay motivated to make lifestyle changes.
Learn more

bioflux device

bioflux for physicians

What is bioflux?*


bioflux consists of an ECG monitoring device, software and access to a monitoring lab. The bioflux software component is an acquisition that is already FDA cleared and a standard for ECG monitoring in hospitals and cardiac clinics.

* User interface may not appear as shown
Pending 510(k) clearance


More on bioflux

biolife for Individuals

What is biolife?


biolife is a health and lifestyle solution that comes with a device to monitor heart-rhythm or ECG—as well as respiration, calories, temperature, physical activity and more.


More on biolife

With soaring rates of cardiovascular disease overwhelming the healthcare system, the opportunity is ripe for technology that enables physicians to diagnose and monitor CVD and patients to take their heart health into their own hands. With physicians’ input and our deep knowledge of the industry, we set about creating solutions that bridge the gap in the marketplace between the healthcare system and the people it treats. That’s why we founded biotricity and continue to focus on R&D to bring technologically advanced solutions to market in order to help physicians diagnose and monitor patients—and help consumers make successful lifestyle changes after initial diagnosis.

Investor Information

biotricity to Demonstrate its IoT Medical Device at AT&T’s Shape

biotricity inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote monitoring solutions, will demonstrate its revolutionary IoT-connected medical device at Shape, at AT&T Tech Expo being held on July 15–16, 2016 at AT&T Park in San Francisco, CA.

More

Innovation in Wearable Devices in the Medical Sector Surge

While wearable technologies become more of a trend and more user friendly, there is an entire segment of wearable devices that is not being discussed often, but on the rise – medical wearable devices. Such devices are used to monitor blood sugar level, sleep apnea disease, blood pressure levels, heart rates, sleep patterns, skin temperatures and more. biotricity (OTC: BTCY), Siemens AG (OTC: SIEGY), Fitbit Inc. (NYSE: FIT), Alphabet Inc. (NASDAQ: GOOGL) Medtronic PLC (NYSE: MDT)

More

biotricity CEO Pedigree on Par with Worldwide Tech Giants

Now the world is introduced to Waqaas Al-Siddiq, a brilliant young Indian-Canadian who founded a medical technology firm called biotricity inc. (OTCQB: BTCY) that will revolutionize cardiac monitoring and treatment by relaying meaningful heart data from patient to doctor in real time, at all times, thereby avoiding adverse incidents that could lead to extended hospital stays, and even death.

More

Meet Our Team

 

For more information about biotricity, bioflux or biolife—or for media inquiries, please get in touch with us below:





 


275 Shoreline Drive, Suite 150
Redwood City CA 94065
1.800.590.4155

75 International Blvd, Suite 300
Toronto ON M9W 6L9
1.416.214.4216